Contraceptive Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Contraceptive Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Contraceptive Drugs Market


The contraceptive drug market size was valued at USD 18.57 billion in 2023, and the market is now projected to grow from USD 19.18 billion in 2024 to USD 37.22 billion by 2032, exhibiting a CAGR of 8.2% during the forecast period of 2024-2032.

The demand for contraceptive medications was majorly hampered by the COVID-19 epidemic. A number of causes, including disruptions in the supply chain, were blamed for this drastic fall in revenues. Family planning and contraceptive drugs programs have also been severely disrupted in numerous nations. The pandemic overall affected the contraceptive drug market growth.

With numerous campaigns and public awareness initiatives, non-profitable organizations and local, state, and healthcare institutions are placing an increasing emphasis on enhancing women's sexual and reproductive health. The awareness was needed to be spread amongst adults in the rural area so as to secure their sexual health overall. These for-profit and nonprofit organizations encourage the public to use contraceptive methods and raise knowledge of the different options available, particularly the rising popularity of these medications. This is the major factor influencing the contraceptive drugs market share.

Opposition to traditional means of contraceptive drugs is growing as a result of technological improvements and more knowledge about contemporary options, such as injectables, topical medications, and oral contraceptive tablets. Modern approaches are more likely to succeed while providing greater protection against STDs than conventional medications and surgeries. As a result, the general public is experiencing a rise in the demand for and adoption of contemporary methods and products, like medications and sterilization.

Comprehensive Analysis of Contraceptive Drugs Market

The market is divided into oral, injectable, and patch categories based on the product. Progestin-only tablets and combination contraceptives are the two further subcategories within the oral section. Due to the increased use of oral medications in both developed and developing nations worldwide, the oral sector held the largest market share. Due to the oral medications' disproportionate clinical advantages over injectables and patches, there has been a spike in the contraceptive drugs market demand.

North America market was accounted to be worth USD 7.27 billion in 2023. One of the main reasons North America dominated the world in 2023 is the high level of knowledge about birth control pills among this particular region’s population, as well as the rapidly rising number of childbearing women and the fertility rate.

There are many domestic generic medicine makers and a small number of foreign participants in the fragmented global market. To obtain a margin and periphery over other companies, the market's leading players concentrate on strategic partnerships. Key companies and top players in the market include Pfizer Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), AbbVie Inc. (U.S.), Agile Therapeutics (U.S.), and Piramal Enterprises Ltd. (India).

In August 2023,Lupin company’s Turqoz (Norgestrel and Ethinyl Estradiol Tablets USP) was approved by the US FDA. The Lo/Ovral-28 pills made by Wyeth Pharmaceuticals LLC have a generic counterpart in this.

Segmentation Table

Attribute Details

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 8.2% from 2024-2032

Unit Value (USD billion)

Segmentation

By Product

Oral

Combined Contraceptives

Progestin-only Pills

Injectable

Patches

By End-User

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Clinics

Online Channels

Public Channels & NGOs

Others

By Region By Region

North America (By Product, By Distribution Channel, and By Country)

U.S. (By Product)

Canada (By Product)

Europe (By Product, By Distribution Channel, and By Country/Sub-region)

U.K. (By Product)

Germany (By Product)

France (By Product)

Italy (By Product)

Spain (By Product)

Scandinavia (By Product)

Rest of Europe (By Product)

Asia Pacific (By Product, By Distribution Channel, and By Country/Sub-region)

Japan (By Product)

China (By Product)

India (By Product)

Australia (By Product)

Southeast Asia (By Product)

Rest of Asia Pacific (By Product)

Latin America (By Product, By Distribution Channel, and By Country/Sub-region)

Brazil (By Product)

Mexico (By Product)

Rest of Latin America (By Product)

Middle East & Africa (By Product, By Distribution Channel, and By Country/Sub-region)

GCC (By Product)

South Africa (By Product)

Rest of Middle East & Africa (By Product)